Latest News

PACE-B trial: Five-fraction SBRT noninferior to conventional radiotherapy in prostate cancer
PACE-B trial: Five-fraction SBRT noninferior to conventional radiotherapy in prostate cancer

October 17th 2024

At 5 years, 95.8% of patients in the SBRT arm were free from biochemical or clinical failure compared with 94.6% of patients in the control radiotherapy arm.

68Ga-PSMA and 18F-Fluciclovine demonstrate ability to alter radiation target volumes
68Ga-PSMA and 18F-Fluciclovine demonstrate ability to alter radiation target volumes

October 16th 2024

FDA accepts new drug application for UGN-102 in NMIBC
FDA accepts new drug application for UGN-102 in NMIBC

October 16th 2024

Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Is video-based research feasible for pediatric urology visits?

October 16th 2024

18F rhPSMA-7.3 PET/MRI demonstrates high detection in recurrent prostate cancer
18F rhPSMA-7.3 PET/MRI demonstrates high detection in recurrent prostate cancer

October 15th 2024

Latest Videos

Latest News

© 2024 MJH Life Sciences

All rights reserved.